Cargando…

Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis

Objective To investigate whether a single optimal vaccination strategy exists across countries to deal with a future influenza pandemic by comparing the cost effectiveness of different strategies in various pandemic scenarios for three European countries. Design Economic and epidemic modelling study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lugnér, Anna K, van Boven, Michiel, de Vries, Robin, Postma, Maarten J, Wallinga, Jacco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395306/ https://www.ncbi.nlm.nih.gov/pubmed/22791791 http://dx.doi.org/10.1136/bmj.e4445

Ejemplares similares

Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster
por: van Lier, Alies, et al.
Publicado: (2015)

Variation in loss of immunity shapes influenza epidemics and the impact of vaccination
por: Woolthuis, Rutger G., et al.
Publicado: (2017)

Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes
por: de Boer, Pieter T., et al.
Publicado: (2020)

Nowcasting pandemic influenza A/H1N1 2009 hospitalizations in the Netherlands
por: Donker, Tjibbe, et al.
Publicado: (2011)

Joint modelling of serological and hospitalization data reveals that high levels of pre-existing immunity and school holidays shaped the influenza A pandemic of 2009 in The Netherlands
por: te Beest, Dennis E., et al.
Publicado: (2015)

Estimation of Vaccine Efficacy and Critical Vaccination Coverage in Partially Observed Outbreaks
por: van Boven, Michiel, et al.
Publicado: (2013)

The Effects of Influenza Vaccination of Health Care Workers in Nursing Homes: Insights from a Mathematical Model
por: van den Dool, Carline, et al.
Publicado: (2008)

Discrimination of Influenza Infection (A/2009 H1N1) from Prior Exposure by Antibody Protein Microarray Analysis
por: te Beest, Dennis, et al.
Publicado: (2014)

Mathematical Models in Infectious Disease Epidemiology
por: Kretzschmar, Mirjam, et al.
Publicado: (2009)

The impact of national vaccination policy changes on influenza incidence in the Netherlands
por: McDonald, Scott A., et al.
Publicado: (2016)

Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men
por: Xiridou, Maria, et al.
Publicado: (2013)

Comparing Cost-Effectiveness Results for a Vaccine Across Different Countries Worldwide: What Can We Learn?
por: Standaert, Baudouin, et al.
Publicado: (2014)

29. Impact of Enhanced Influenza Vaccines on Direct Healthcare Costs for the U.S. Elderly: A Comprehensive Real-World Evaluation of Adjuvanted Trivalent Influenza Vaccine Compared to Trivalent High-Dose Influenza Vaccine for the 2018–19 Influenza Season
por: Postma, Maarten, et al.
Publicado: (2020)

Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis
por: Sandmann, Frank G., et al.
Publicado: (2022)

Budget constraint and vaccine dosing: a mathematical modelling exercise
por: Standaert, Baudouin A, et al.
Publicado: (2014)

Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands
por: van Boven, Job FM, et al.
Publicado: (2016)

Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA
por: White, Laura Forsberg, et al.
Publicado: (2009)

Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model
por: de Vries, Robin, et al.
Publicado: (2010)

The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia
por: de Boer, Pieter T., et al.
Publicado: (2018)

Economic Assessment of High-Dose Versus Adjuvanted Influenza Vaccine: An Evaluation of Hospitalization Costs Based on a Cohort Study
por: van Aalst, Robertus, et al.
Publicado: (2021)

A Measles Epidemic Threshold in a Highly Vaccinated Population
por: Wallinga, Jacco, et al.
Publicado: (2005)

Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis
por: Bogaards, Johannes A, et al.
Publicado: (2015)

Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories
por: Kelso, Joel K, et al.
Publicado: (2013)

Cost-Effectiveness Analysis of BCG Vaccination against Tuberculosis in Indonesia: A Model-Based Study
por: Machlaurin, Afifah, et al.
Publicado: (2020)

A Model-based Assessment of Oseltamivir Prophylaxis Strategies to Prevent Influenza in Nursing Homes
por: van den Dool, Carline, et al.
Publicado: (2009)

Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
por: Westerink, Lotte, et al.
Publicado: (2022)

Ring Vaccination and Smallpox Control
por: Kretzschmar, Mirjam, et al.
Publicado: (2004)

Long-Term Correlation between Influenza Vaccination Coverage and Incidence of Influenza-Like Illness in 14 European Countries
por: Spruijt, Ineke T., et al.
Publicado: (2016)

Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review
por: Straetemans, Masja, et al.
Publicado: (2007)

Sex-Specific Immunization for Sexually Transmitted Infections Such as Human Papillomavirus: Insights from Mathematical Models
por: Bogaards, Johannes A., et al.
Publicado: (2011)

Early cost-effectiveness analysis of screening for preeclampsia in nulliparous women: A modelling approach in European high-income settings
por: Zakiyah, Neily, et al.
Publicado: (2022)

Frequency of Adverse Events after Vaccination with Different Vaccinia Strains
por: Kretzschmar, Mirjam, et al.
Publicado: (2006)

Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model
por: Dolk, Christiaan, et al.
Publicado: (2016)

Correction: Frequency of Adverse Events after Vaccination with Different Vaccinia Strains
por: Kretzschmar, Mirjam, et al.
Publicado: (2006)

Retrospective public health impact of a quadrivalent influenza vaccine in the United States
por: Crépey, Pascal, et al.
Publicado: (2015)

Doing Mathematics with Aftermath of Pandemic Influenza 2009
por: Cho, Hae-Wol, et al.
Publicado: (2015)

The 2009 influenza A (H1N1) pandemic: Management and vaccination strategies in The Netherlands
por: van der Sande, M.A.B., et al.
Publicado: (2012)

Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
por: Nham, Eliel, et al.
Publicado: (2023)

Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries
por: Mokri, Hamraz, et al.
Publicado: (2022)

Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017–2018 Influenza Season
por: Pelton, Stephen I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r4hq86g3k3khlppjor60e1vc61